References
- Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4(3):167–76. doi:https://doi.org/10.1016/S1470-2045(03)01021-0
- Andia ME, Hsing AW, Andreotti G, Ferreccio C. Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study. Int J Cancer. 2008;123(6):1411–6. doi:https://doi.org/10.1002/ijc.23662
- Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990;247(4938):49–56. doi:https://doi.org/10.1126/science.2294591
- Fearon ER, Vogelste B. A genetic mode l for colorectal tumorigenesis. Cell. 1990;61(5):759–67. doi:https://doi.org/10.1016/0092-8674(90)90186-I
- Itoh F, Hinoda Y, Ohe M, Ohe Y, Ban T, Endo T, Imai K, Yachi A. Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer. 1993;53(2):260–3. doi:https://doi.org/10.1002/ijc.2910530215
- Cha PC, Zembutsu H, Takahashi A, Kubo M, Kamatani N, Nakamura Y. A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population. J Hum Genet. 2012;57(4):235–7. doi:https://doi.org/10.1038/jhg.2012.9
- Rai R, Sharma KL, Tiwari S, Misra S, Kumar A, Mittal B . DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. No.: Gene-D-12-01446). Gene. 2013;518(2):303–9. doi:https://doi.org/10.1016/j.gene.2013.01.019
- Malik MA, Gupta A, Zargar SA, Mittal B. Role of genetic variants of deleted in colorectal carcinoma (DCC) polymorphisms and esophageal and gastric cancers risk in Kashmir Valley and meta-analysis. Tumour Biol. 2013;34(5):3049–57. doi:https://doi.org/10.1007/s13277-013-0870-4
- Toma M, Stavarachi M, Cimponeriu D, Apostol P, Cojocaru M, Belusica L, Panduru N, Radu I, Gavril L. P53 and DCC Polymorphisms and the risk for colorectal cancer in Romanian patients – A preliminary study. Tom. 2009; 2:162–5.
- Djansugurova L, Zhunussova G, Khussainova E, Iksan O, Afonin G, Kaidarova D, Parker MI. Association of DCC, MLH1, GSTT1, GSTM1, and TP53 gene polymorphisms with colorectal cancer in Kazakhstan. Tumor Biol. 2015;36(1):279–89. doi:https://doi.org/10.1007/s13277-014-2641-2
- Krimpenfort P, Song JY, Proost N, Zevenhoven J, Jonkers J, Berns A. Deleted in colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours. Nature. 2012;482(7386):538–41. doi:https://doi.org/10.1038/nature10790
- Chandra V, Kim JJ, Gupta U, Mittal B, Rai R. Impact of DCC (rs714) and PSCA (rs2294008 and rs2976392) gene polymorphism in modulating cancer risk in Asian population. Genes. 2016;7(2):9. doi:https://doi.org/10.3390/genes7020009
- Schmitt CA, Thaler KR, Wittig BM, Kaulen H, Büschenfelde CKMZ, Dippold WG . Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation. Br J Cancer. 1998;77(4):588–94. doi:https://doi.org/10.1038/bjc.1998.95
- Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T, Hirohashi S. Frequent loss of heterozygosity at DCC locus in gastric cancer. Cancer Res. 1992;52(11):3099–102.
- Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, et al. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res. 1992;52(23):6525–30.
- Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ. Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved?Oncogene. 1991; 6(2):311–5.
- Gao X, Honn KV, Grignon D, Sakr W, Chen YQ. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res. 1993;53(12):2723–7.
- Höhne MW, Halatsch ME, Kahl GF, Weinel RJ. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 1992;52(9):2616–9.
- Scheck AC, Coons SW. Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res. 1993;53(23):5605–9.
- Cho JH, Noguchi M, Ochiai A, Hirohashi S. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction. Lab Invest. 1996;74(4):835–41.
- Fang DC, Jass JR, Wang DX. Loss of heterozygosity and loss of expression of DCC gene in gastric cancer. J Clin Pathol. 1998;51(8):593–6. doi:https://doi.org/10.1136/jcp.51.8.593
- Candusso ME, Luinetti O, Villani L, Alberizzi P, Klersy C, Fiocca R, Ranzani GN, Solcia E. Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value. J Pathol. 2002;197(1):44–50. doi:https://doi.org/10.1002/path.1105